PUBLISHER: The Business Research Company | PRODUCT CODE: 1751140
PUBLISHER: The Business Research Company | PRODUCT CODE: 1751140
Tick-borne encephalitis (TBE) is a viral infection transmitted to humans through the bite of an infected tick, primarily the Ixodes species. The virus targets the central nervous system, leading to brain inflammation (encephalitis). Symptoms can range from mild flu-like signs to severe neurological issues, including fever, headache, confusion, and, in some cases, paralysis or seizures.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main products used for tick-borne encephalitis (TBE) include TBE vaccines, tick repellents, diagnostic tests, and antiviral drugs. TBE vaccines are biological preparations designed to stimulate the immune system to recognize and fight the TBE virus. The virus is caused by several types, including the European tick-borne encephalitis virus, Siberian tick-borne encephalitis virus, and Far Eastern tick-borne encephalitis virus. These vaccines can be administered through parenteral and other routes. They are distributed via both online and offline channels and are used by travelers, outdoor enthusiasts, healthcare providers, and research institutions.
The tick borne encephalitis market research report is one of a series of new reports from The Business Research Company that provides tick borne encephalitis market statistics, including tick borne encephalitis industry global market size, regional shares, competitors with a tick borne encephalitis market share, detailed tick borne encephalitis market segments, market trends and opportunities, and any further data you may need to thrive in the tick borne encephalitis industry. This tick borne encephalitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The tick borne encephalitis market size has grown strongly in recent years. It will grow from $9.77 billion in 2024 to $10.56 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth observed in the historic period can be attributed to several factors, including a growing geriatric population, an increasing incidence of tick bites, a rise in the disease's prevalence, and a growing demand for effective and safe vaccines.
The tick borne encephalitis market size is expected to see strong growth in the next few years. It will grow to $14.21 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth projected for the forecast period can be attributed to factors such as the rising prevalence of tick-borne encephalitis, increasing government funding for healthcare facilities, a growing incidence of Japanese encephalitis, expanding government initiatives, and the rising middle class. Key trends during this period include advancements in vaccine development, technological innovations in diagnostics and therapeutics, government initiatives for surveillance and control, environmental changes affecting disease transmission, and enhanced government efforts for infectious disease control.
The growing effects of climate change are expected to accelerate the expansion of the tick-borne encephalitis market in the future. Climate change refers to the long-term changes in global temperature and weather patterns, primarily caused by human activities such as fossil fuel consumption and deforestation. The rise in global temperatures is a direct result of excessive fossil fuel burning, which releases significant amounts of greenhouse gases such as carbon dioxide and methane, trapping heat in the atmosphere. This increase in temperature helps expand the habitats of ticks that carry diseases, due to warmer conditions and milder winters, leading to higher infection rates and an increased demand for diagnostic tests, vaccines, and antiviral treatments. For instance, in November 2024, the World Meteorological Organization (WMO) reported that from January to September 2024, the global mean surface air temperature was 1.54°C above the pre-industrial average (+-0.13°C margin of uncertainty), driven by the warming effects of the El Nino event. Consequently, the ongoing climate change is driving the growth of the tick-borne encephalitis market.
The increase in international travel is anticipated to further boost the growth of the tick-borne encephalitis market. International travel involves the movement of people across borders for reasons such as tourism, business, education, or migration. As disposable income rises, more people are able to afford leisure, business, and educational trips internationally. This rise in international travel contributes to the demand for tick-borne encephalitis treatment, as more travelers visit regions where the disease is endemic, increasing their exposure to infected ticks and the need for preventive vaccinations and medical care following exposure. For example, in January 2025, the United Nations World Tourism Organization reported that an estimated 1.4 billion people traveled internationally in 2024, marking a near-full recovery to pre-pandemic levels (99%), with 140 million more international arrivals compared to 2023. This surge in travel drives the growth of the tick-borne encephalitis market.
The rising government investment in healthcare is expected to accelerate the growth of the tick-borne encephalitis market moving forward. Government funding refers to financial support provided to organizations, projects, or individuals to promote public services, economic development, research, or other policy goals. This increase in funding is primarily due to heightened investments in public health and infrastructure, as governments allocate more resources to bolster healthcare systems, support economic recovery, and boost research and development. Government funding has a positive impact on the tick-borne encephalitis market by supporting vaccination campaigns, expanding immunization efforts in endemic regions, reducing infection rates, and increasing public access to preventive healthcare. For example, in May 2024, a report from the Office for National Statistics indicated that in 2023, the UK government's expenditure accounted for the majority of healthcare financing, totaling $309 billion (£239 billion), or 81.9% of overall healthcare spending. Thus, growing government healthcare funding is driving the growth of the tick-borne encephalitis market.
Major players in the tick borne encephalitis market are Pfizer Inc., Health Mil, Sanofi Pasteur, Novartis AG, GlaxoSmithKline (GSK) Plc, Mayo Clinic, Superdrug Health Clinic, Bavarian Nordic, Passport Health, Valneva SE, Microgen, Travel Doctor-TMVC, DIESSE Diagnostica Senese S.p.A., The Native Antigen Company, Fleet Street Clinic, Progen, Smarta Healthcare, QED Bioscience Inc., Serion Immunologics, Chumakov Federal Scientific Center.
Europe was the largest region in the tick borne encephalitis market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in tick-borne encephalitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tick-borne encephalitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The tick-borne encephalitis market consists of sales of immune globulins, protective clothing and tick barriers, and surveillance and monitoring systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tick Borne Encephalitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on tick borne encephalitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for tick borne encephalitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tick borne encephalitis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.